ECS Botanics Holdings Ltd (ASX:ECS) managing director Nan-Maree Schoerie brings Proactive’s Elisha Newell up to speed on the company’s value proposition ahead of the Peak Asset Management Microcap Conference on Thursday, July 13
ECS Botanics (ECS) has entered two offtake agreements worth a combined more than $11.9 million to supply medicinal cannabis dried flower in Australia. The company announced it will supply Melbourne-based Entoura with Good Manufacturing Practice (GMP) medicinal cannabis dried flower, worth $10.2 million over three years. Entoura supplies and develops high-quality medicinal cannabis products, but also…
Medicinal cannabis company, ECS Botanics (ECS) has launched the sale of two assets and secured a new loan facility. The company agreed to sell its hemp food and wellness business for $250,000 to Ananda Food, with contract completion expected in August upon the finalisation of due diligence. In addition, the company has planned to sell its…
ECS Botanics (ECS) has reached financial settlement of its Tasmanian medicinal cannabis business and assets for $3 million. The medicinal cannabis company agreed to sell its subsidiary, TasCo, which holds its Tasmanian operations and farm, to Blue Buffalo for $3 million. On October 24, the company announced to the market it had entered an unconditional…
Shares in ECS Botanics (ASX: ECS) rose by more than 22 per cent this morning after the Victorian medicinal cannabis grower and manufacturer announced its third supply contract win in just over three months, taking the total value of agreements reached since late June to $35.9 million.
ECS Botanics Ltd (ASX:ECS) managing director Nan-Maree Schoerie tells Proactive the company is an Australian medicinal cannabis cultivator and manufacturer with operations in northwest Victoria.
ECS Botanics (ECS) has reported significant growth in its December quarter, achieving its key milestone of positive quarterly cashflow.
ECS Botanics has had another incredibly productive quarter, producing revenue of over $2m in Q3. And with the European majors opening up, the vertically integrated company says it’s in a great position with harvesting currently underway. Benchmark Aussie medicinal cannabis play ECS Botanics (ASX:ECS) has delivered more than $2million in revenue for the third quarter, as demand…
Cannabis has been used as medicine for thousands of years. Ancient Indian, Chinese, and Egyptian civilisations have all employed it to cure various illnesses. But increasing recreational use and perceived harm to society meant that it has been outlawed in many countries since the early 20th century. In the US for example, cannabis was restricted…
The company flagged additional revenue opportunities in the year ahead as it establishes traction as the leading B2B supplier in the Australian cannabis market as the supply agreement with Canngea finalised. Leading medicinal cannabis company ECS Botanics (ASX:ECS) continues to execute on a rapid growth trajectory, as it gains traction as the supplier of choice for a…
In every sector of culture and society, a shift towards greater diversity is moving the needle on what, and who is considered “typical”. This is as true in the realm of cannabis consumption as anywhere else, with the stereotype of surfer dude stoners and glazed and confused couch potatoes making way for women as the…
